TrialAdvances in therapy2017

Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis.

Rachel Harrington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.